In the afternoon, the innovative drugs sector experienced a volatile decline, with Beigene falling more than 10%. Zhixiang Jintai, Fangsheng Pharmaceutical, Humanwell Healthcare, Inner Mongolia Furui Medical Science, and Sichuan Kelun Pharmaceutical also followed the decline.
创新药板块震荡回落 百济神州跌超10%
The innovative drugs sector has experienced a volatile decline, with Beigene falling more than 10%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.